Clinical Trial Update: Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial assessing safety and preliminary effectiveness of NVD-001 for low grade degenerative lumbar spondylolisthesis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spondylolisthesis

Drugs mentioned

• NVD-001

Snippet

Sponsor: Novadip Biosciences | Conditions: Spondylolisthesis | Phase 1, Phase 2 | Status: COMPLETED